This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Leadership
Integrated collaboration is highly valued at Noul.
Our entire team strive to apply our expertise in developing novel solutions to tackle challenging problems.
Leadership
-
David Lim Chief Executive Officer As the founder and CEO of Noul, David Lim oversees the overall management of the company. He is committed to growing Noul into a global leader in the biohealthcare sector, creating a valuable enterprise that contributes to humanity. Prior to founding Noul, he worked as an investor in the biohealthcare field and led research and development at a medical device company. Since the early stages of Noul, he has led the company’s innovative technology development as an engineering leader. He holds a degree in Electrical Engineering from Seoul National University. -
Peter Kim Chief Production Officer As one of the founding members and CPO (Chief Production Officer) of Noul, Peter Kim is responsible for the company’s end-to-end production processes, encompassing procurement, manufacturing, and quality management. From the outset, he has been dedicated to building Noul in pursuit of meaningful work that benefits more people. Before starting Noul, Peter was a researcher at LG Electronics and later an attorney at KT Corp. He earned a master’s degree in Electrical and Computer Engineering from Seoul National University and a law degree from Jeju University Law School. -
Justin Ahn Chief Operating Officer As COO (Chief Operating Officer) of Noul, Justin Ahn is responsible for overseeing the company’s overall operations and sustainability strategy. Since the company’s early days, he has been dedicated to guiding its growth into a sustainable company that meets global standards. He is an expert in corporate management systems and was the first in Korea to serve as a CSO(Chief Sustainability Officer). Before joining Noul, Justin worked at POSCO Research Institute, the British Standards Institution, and Slowalk. -
TH Kim Managing Director of noul GmbH As Managing Director of noul GmbH (Noul Europe), he is responsible for overseeing collaborations with international organizations to drive public sector projects and facilitate global expansion of Noul's products. He joined the company due to Noul's potential in the field of global health and the integrity and capacity of its staff members. He has worked at investment banks and held executive positions at Credit Suisse after obtaining B.A. in Business Administration from Seoul National University. After consecutively being awarded with Master and Ph.D. in Public Health at the same university, he has contributed to global health as a consultant at the World Health Organization and an investment officer at the Asian Infrastructure Investment Bank making himself as an expert both in international finance and global health. -
Marco Chung VP of Sales As VP of Sales at Noul, he oversees Asia, the Middle East, Africa and North America, leading the global growth and partnerships of miLab™, Noul's AI-powered diagnostic platform. He joined Noul to help close gaps in diagnostic access through innovative technology. Over 22 years, he has held sales and marketing leadership and executive roles at leading diagnostics companies, including Roche Diagnostics Korea, SD Biosensor and Abbott Korea. He brings deep expertise in strategic alliances with global partners and extensive experience in international public procurement with WHO, UNICEF and the Global Fund. -
Naz Park Director of the Corporate Research Institute Naz Park leads product development at Noul as the Director of the Corporate Research Institute. Prior to joining Noul, he spent 16 years as a clinical laboratory scientist in the department of laboratory medicine at a university hospital, and further expanded his expertise into data and AI through a master's program in Precision Medicine Big Data. With deep healthcare domain knowledge and a strong understanding of AI, Naz joined Noul driven by a commitment to developing products that deliver meaningful value in real-world clinical settings. -
Samuel Song Head of Bio R&D Samuel joined Noul to contribute to realizing innovative technology as a bioengineer. He leads the Bio R&D team at Noul and contributes to improving medical accessibility in harsh environments by developing cartridge-based automated sample preparation. He graduated from Seoul National University with B.S. and Ph.D. degrees in electrical and computer engineering.
Advisors
- Scientific Advisors
-
Hans-Peter Beck Ph.D. University of Basel, Swiss TPH "Dr. Hans-Peter Beck is a Professor emeritus for Molecular Parasitology at the University of Basel and worked for 25 years at the Swiss Tropical and Public Health Institute (Swiss TPH) in Basel. He works at the team of the Innovation office of the University of Basel as scientific advisor. Dr. Beck’s expertise is in the molecular understanding of tropical diseases with focus on malaria. His main contribution to the field was the establishment of molecular genotyping methods in clinical and control trials for antimalarial drugs, as well as the understanding of protein-protein interactions within the malaria parasite Plasmodium falciparum.
Dr. Beck obtained his PhD from the University of Tübingen, Germany, and before he joined the Swiss TPH, he held several scientific positions at the University of Edinburgh and Glasgow, UK; at the Walter and Eliza Hall Institute (WEHI), Melbourne, Australia; at the Papua New Guinea Institute of Medical Research (PNG IMR); and at the University of Witten-Herdecke, Germany." -
Hidde Ploegh Ph.D. Harvard Medical School, Boston Children's Hospital "Professor Ploegh is a faculty member at Boston Children's Hospital (Harvard Medical School)
and senior investigator in its program in cellular and molecular medicine. As an immunologist, biochemist and biotechnologist, he is a pioneer in developing the 'sortagging method' used in protein engineering. He has contributed to our understanding of how certain viruses can avoid detection by the immune system. The sortagging method has a wide range of applications such as quantitative labeling, modification of certain proteins for therapeutic purposes etc. He contributed to the development of a microengraving method for high-throughput single cell assays and nanobody applications. Professor Ploegh was previously a member of the Whitehead Institute at the Massachusetts Institute of Technology and on the faculty of Harvard Medical School as the director of its graduate program in immunology. He is a member of EMBO (1986), a correspondent of the Royal Netherlands Academy of Arts and Sciences (1997) , a fellow of the American Academy of Arts and Sciences (2000) and a member of the National Academy of Sciences (2016)." -
Jong Hye Woo Ph.D. Harvard Medical School, Massachusetts General Hospital Dr. Jong Hye Woo is an associate professor in the Department of Radiology at Harvard Medical School and Massachusetts General Hospital. Dr. Woo received a bachelor's degree in Electrical Engineering from Seoul National University, and subsequently earned his master's and Ph.D. degrees from the University of Southern California. He has been awarded the Best Dissertation Award from the USC Viterbi School of Engineering, the NIH/NIDCD K99/R00 Pathway to Independence Award, and the Distinguished Investigator Award from the Academy of Radiology and Biomedical Imaging Research. As a top-class researcher, he focuses on medical image analysis and machine/deep learning for various clinical applications. -
KiTae Nam Ph.D. Nano System Institute, Seoul National University Prof. Ki Tae Nam is a professor in the department of materials science and engineering at the Seoul National University (SNU). He was a postdoc at the Lawrence Berkeley National Lab after he got a PhD degree at MIT and B.S./M.S. at SNU. He is pioneering new research at the interface of biological systems and nanomaterials as an effort to make enzyme mimetic materials. Recently, his group demonstrated that peptides can program the atomic morphology of nanomaterials for biosensors and electrochemical devices. -
Kyu-Hwan Jung Ph.D. Samsung Advanced Institute for Health Science & Technology, SKKU Dr. Kyu-Hwan Jung is a professor at the Samsung Advanced Institute for Health Sciences & Technology at Sungkyunkwan University. In 2015, he co-founded VUNO, a company specializing in deep learning-based medical data analysis, where he served as the Chief Technology Officer and led the research and development efforts. After earning his Ph.D. in Industrial and Management Engineering from POSTECH, he worked on big data and AI-related research and development at SK Telecom and Samsung Electronics' Advanced Institute of Technology. He is currently recognized as one of the leading experts in medical artificial intelligence in South Korea.